Showing 1521-1530 of 7116 results for "".
Conquer Burnout
https://practicaldermatology.com/topics/practice-management/conquer-burnout/18732/Recognizing the signs of burnout is the first step to conquering this epidemic among physicians. Leading dermatologists Brian Berman, MD, PhD and Neil Sadick, MD talk to host Neal Bhatia, MD about the latest research into physician burnout and the probable causes, from an increase in legislative issRisk In Your Portfolio
https://practicaldermatology.com/topics/practice-management/risk-in-your-portfolio/18588/Do you know your risk score? Physicians must understand their personal tolerance for risk as well as the level of risk in their current portfolios. If there is a mismatch, how do you rectify the disconnect. Bob Peelman, CFP, of OJM Group, explains. ABOUT THE AUTHORAdvances in Laser Tattoo Removal
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/advances-in-laser-tattoo-removal/18607/Laser tattoo removal continues to rise in popularity largely due to advances in technology and technique. In particular, the DeScribe Transparent PFD Patch has helped make tattoo removal treatment sessions more tolerable for patients and expedite clearance of tattoos. Jeremy A. Brauer, MD Director oConsolidation or Competition: The Road to Optimization
https://practicaldermatology.com/topics/practice-management/consolidation-or-competition-the-road-to-optimization/18769/What's next for the dermatology/aesthetics industry? Joel Schlessinger, MD, founder of Cosmetic Surgery Forum, describes what has taken place in the aesthetic space and predicts what's next, especially in the laser/device space.Protecting Assets in a Divorce
https://practicaldermatology.com/topics/practice-management/protecting-assets-in-a-divorce/18771/Statistics show that half of marriages end in divorce. Financial consequences can be significant. OJM Group principal David Mandell, JD, MBA, discusses how physicians can protect their assets in the pre-marital and the marital stages in the event of a divorce. Always contact local counsel before taChemoprevention Strategies for AK Patients
https://practicaldermatology.com/topics/skin-cancer-photoprotection/chemoprevention-strategies-for-ak-patients/18822/Neal Bhatia, MD, Chief Medical Editor of Practical Dermatology®, provides strategies for treating actinic keratoses, as well as for prevention and management. He discusses the importance of sun protection and photodamage prevention, and says the key to treatment and maintenance is combination therapPearls for Injectables: From Toxins to Fillers
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/pearls-for-injectables-from-toxins-to-fillers/18628/Ava Shamban, MD shares her rationale for thinking of the face in three treatment areas for rejuvenation procedures—upper, middle, and lower. Devising strategies with injections targeted to each area will help patients achieve more natural recountouring while achieving the youthful appearance they dePediatric Atopic Dermatitis And Psoriasis
https://practicaldermatology.com/topics/psoriasis/pediatric-atopic-dermatitis-and-psoriasis/18631/Lawrence Eichenfield, MD provides an update on pediatric atopic dermatitis and psoriasis. Unfortunately, he said, many children remain undertreated for their eczema despite the availability of effective treatments and a number of topical and systemic products on the horizon. Dr. Eichenfield also proThe Rising Costs of Prescription Drugs
https://practicaldermatology.com/topics/practice-management/the-rising-costs-or-prescription-drugs/18677/What's really causing the costs of dermatology prescriptions, especially generics, to skyrocket? Jake Levitt, MD and Mark Lebwohl, MD speak to host Neal Bhatia, MD about what's influencing these rising costs, and who, if anyone, is benefiting. Dr. Levitt talks about the rebate system between manufacValeant Acquires Salix; Actavis Changing Name
https://practicaldermatology.com/series/dermwire-tv/valeant-acquires-salix-actavis-changing-name/18963/Valeant expands its portfolio with the acquisition of GI market leader Salix. Actavis divests Doryx and considers a name change to Allergan. Kythera acquires rights for investigational hair therapies. And Cynosure's 532nm laser delivery system is FDA cleared for PicoSure.